| Revenue growth | Total income stood at 411 crore for Q1 FY27. |
|---|---|
| Margins | EBITDA margin at 19.3%, impacted by new hospital operational drag. |
| Demand visibility | Strong demand-supply gap for organized healthcare in Western India. |
| Management confidence | Balanced; focused on execution of announced projects and Dombivli ramp-up. |
Growth
Revenue reached 411 crore with 19.3% EBITDA margin; mature units see inflation-linked growth while new units grow faster.
Outlook
Management expects Dombivli to break even in the second year of operations (FY28).
Risks
Expansion risks include a 6-7 crore monthly fixed cost at Dombivli and potential margin compression during capacity additions.
Last quarter's promises, checked
Delivered
- Commission Dombivli by Q1 FY27 → Opened ahead of schedule in Feb 2026 (= BEAT)
- Build 1,700 new beds at INR 1.5cr/bed → Maintained average cost guidance (= BEAT)
- Maintain net cash positive status → Gross debt 500cr vs 545cr cash (= BEAT)
Partly delivered
- Indore occupancy target 60% for Phase 2 → Delivered 45-50% (= PARTIAL)
- Dombivli EBITDA burn 2-3cr/month → Actual Q1 drag 9.5cr (~3.1cr/month) (= PARTIAL)
Earnings Call Transcript filed with BSE, NSE: JLHL. Summary written with AI assistance from the document.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹265.65
- Market cap
- ₹8,709 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 46.4×Sector 57.8×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Jupiter Life Line Hospitals reported Q1FY27 revenue growth of 16.2% YoY, while PAT declined 14.7% due to higher depreciation and finance costs from the new Dombivli facility.
Jupiter Life Line Hospitals Q1 FY27 Results: Net Profit ₹37.5 Cr, Down 14.6% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹411 Cr (+16.4% YoY) and net profit of ₹37.5 Cr (-14.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹37.5 Cr · -14.6% YoY
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter reports strong FY26 performance with 15.2% revenue growth to ₹1,499.8cr. Focus remains on greenfield expansion in Western India with asset-heavy ownership model.
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter is aggressively expanding in Western India, leveraging its asset-heavy model to build high-capacity flagship hospitals in Mumbai and Pune.